Just goes to prove the money is out there and available if you have a management team that knows what they are doing.

Good find, thanks.

Also, lots of work being done on long Covid based on the attached excerpt from Nature. Unfortunately RVX will probably never be in a financing position to capitalize on this work.

Analysis uncovers a long COVID gene

The first genome-wide hunt to find genetic risk factors for long COVID has yielded a hit: a DNA sequence near a gene called FOXP4, which is active in the lungs and in some immune cells. The study used data collected from 6,450 people with long COVID across 16 countries. Researchers hope that this analysis will be just the beginning: a vast amount of data are required to unpick a disorder as complex as long COVID, which has been associated with more than 200 symptoms, including severe fatigue, nerve pain and difficulties with concentration and memory.

Nature | 3 min read
Reference: medRxiv preprint (not peer reviewed)

GLTA

Toinv